Product Information
APTENSIO XR 40 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $7.9434 per EA under NDC 42858040545. Its NADAC has been published 271 times since Mar 21, 2018.
FDA first approved this application on Apr 17, 2015. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040545
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831FDA Approved
4/17/2015
TE Code
AB3
On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 40 MG CAPSULE has been published 271 times since Mar 21, 2018, and over the history we have for it it has risen 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9434 per EA |
|---|---|
| All-time high | $8.0102 (Oct 16, 2024) |
| All-time low | $6.9134 (Mar 21, 2018) |
| 52-week high | $7.9533 |
| 52-week low | $7.9336 |
| Median price | $7.9434 |
| Average price | $7.8368 |
| Largest weekly change | +10.0% (Jun 6, 2018) |
| Weeks tracked | 271 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APTENSIO XR 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 40 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $7.9434 per EA (NDC 42858040545), effective Aug 19, 2026.
How has the price of APTENSIO XR 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 40 MG CAPSULE has risen 14.9%. It has been tracked across 271 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 40 MG CAPSULE?
Since Mar 21, 2018, the NADAC for APTENSIO XR 40 MG CAPSULE has ranged from a low of $6.9134 (Mar 21, 2018) to a high of $8.0102 (Oct 16, 2024), with a median of $7.9434 per EA.
Are there cheaper alternatives to APTENSIO XR 40 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 40 MG CAP, is $1.3833 per EA — about 83% below APTENSIO XR 40 MG CAPSULE.
Who manufactures APTENSIO XR 40 MG CAPSULE?
APTENSIO XR 40 MG CAPSULE (NDC 42858040545) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.